Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Total Tests Reported by Year
Total Tests Reported — Resulting in a Customer Report (tests)
Natera Total Tests Reported: 3,342,500.00 tests in FY2025, up 14.2% from a year earlier. That is the highest of the 9 years on record here.
Where the FY2025 figure comes from
“During the year ended December 31, 2025, total reported units were approximately 3,342,500, comprised of approximately 3,288,600 tests reported in our laboratories.”
Source: Form 10-K (FY2025) ↗
Total tests processed that successfully generated a clinical report delivered to the ordering provider or laboratory partner.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Tests Reported — Resulting in a Customer Report (tests) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,342,500.00 | +14.2% | Form 10-K (FY2025) ↗ |
| FY2024 | Dec 31, 2024 | 2,926,400.00 | +22.5% | Form 10-K (FY2025) ↗ |
| FY2023 | Dec 31, 2023 | 2,388,200.00 | +24.4% | Form 10-K (FY2024) ↗ |
| FY2022 | Dec 31, 2022 | 1,919,600.00 | +32.1% | Form 10-K (FY2023) ↗ |
| FY2021 | Dec 31, 2021 | 1,453,500.00 | +51.0% | Form 10-K (FY2022) ↗ |
| FY2020 | Dec 31, 2020 | 962,400.00 | +26.0% | Form 10-K (FY2021) ↗ |
| FY2019 | Dec 31, 2019 | 763,900.00 | – | Form 10-K (FY2020) ↗ |
| FY2017 | Dec 31, 2017 | 268,800.00 | – | Form 10-K (FY2017) ↗ |
| FY2015 | Dec 31, 2015 | 138,200.00 | – | Form 10-K (FY2017) ↗ |
Breakdown
What makes up total Tests Reported
Cite this data
StockData. (2026). Natera Total Tests Reported, annual FY2015–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/vol-tests-reported-total
See every metric in the Natera KPI table. Data updated Nov 2, 2026.